Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.

@article{Tzartzeva2018SurveillanceIA,
  title={Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.},
  author={Kristina Tzartzeva and Joseph Obi and Nicole E Rich and Neehar D Parikh and J. A. Fermin Marrero and Adam Charles Yopp and Akbar K Waljee and Amit G. Singal},
  journal={Gastroenterology},
  year={2018},
  volume={154 6},
  pages={
          1706-1718.e1
        }
}
BACKGROUND & AIMS Society guidelines differ in their recommendations for surveillance to detect early-stage hepatocellular carcinoma (HCC) in patients with cirrhosis. We compared the performance of surveillance imaging, with or without alpha fetoprotein (AFP), for early detection of HCC in patients with cirrhosis. METHODS Two reviewers searched MEDLINE and SCOPUS from January 1990 through August 2016 to identify published sensitivity and specificity of surveillance strategies for overall and… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 48 times over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 63 references

Frequency and work-up of indeterminate nodules during surveillance of hepatocellular carcinoma in patients with cirrhosis

  • A Verma, MA Konerman, B Zhao, AS Lok, ND. Parikh
  • The Liver Meeting 2016 Nov 11-15,
  • 2016

Similar Papers

Loading similar papers…